During the past decade, PAREXEL Early Phase Clinical Unit conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PAREXEL Early Phase Clinical Unit" #1 sponsor was "Astellas Pharma Europe B.V." with 9 trials, followed by "Bial - Portela C S.A." with 3 trials sponsored, "Heptares Therapeutics Limited" with 3 trials sponsored, "Medivir" with 2 trials sponsored and "Samsung Bioepis Co., Ltd." with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PAREXEL Early Phase Clinical Unit" #1 collaborator was "Parexel" with 4 trials as a collaborator, "KCAS" with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator and "Novartis Vaccines" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PAREXEL Early Phase Clinical Unit" are "Healthy" (9 trials), "Healthy Subjects" (7 trials), "Healthy Volunteers" (4 trials), "Pharmacokinetics" (3 trials) and "Pulmonary Arterial Hypertension" (3 trials). Many other conditions were trialed in "PAREXEL Early Phase Clinical Unit" in a lesser frequency.

Most popular intervention types in "PAREXEL Early Phase Clinical Unit" are "Drug" (35 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "ASP3652" (3 trials), "BIA 5-1058" (3 trials), "EC905" (2 trials) and "Itraconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "PAREXEL Early Phase Clinical Unit" are 23 trials for "All" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "PAREXEL Early Phase Clinical Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in PAREXEL Early Phase Clinical Unit, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PAREXEL Early Phase Clinical Unit, 34 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".